Long-term registry-based study of patients with transfusion-dependent β-thalassemia (TDT) or sickle cell disease (SCD) treated with exagamglogene autotemcel (exa-cel) First published 12/03/2025 Last updated 11/02/2026 EU PAS number:EUPAS1000000504 Study Ongoing